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Infections due to multidrug-resistant bacteria have spread in
the world and cause signiﬁcant morbidity and mortality [1]. Bone
and joint infection due to multidrug-resistant bacteria has become
a major problem, limiting the efﬁcacy of targeted treatment and
compromising outcomes. Indeed, antimicrobial options are limited
and extensive surgical procedures are required.
Adjunctive hyperbaric oxygen therapy (HBO) has been reported
as an effective treatment in soft tissue infection caused by
anaerobic bacteria, such as gas gangrene, necrotizing fasciitis and
Fournier’s gangrene. HBO has also been extensively used to
improve wound healing in the treatment of diabetic foot infections
and osteitis [2]. We report an apparent successful treatment of
OXA-48 type carbapenemase-producing K. pneumonia osteomye-
litis with HBO without any concomitant antimicrobial.* Corresponding author at: Centre Interrégional de Référence des Infections
Ostéo-Articulaires Méditerranée Sud; Service des Maladies Infectieuses, CHU de la
Conception, 147, boulevard Baille, Marseille, France.
E-mail address: andreas.stein@ap-hm.fr (A. Stein).
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In December 2012, a 65-year-old French man was admitted to
the infectious disease unit of the Laveran military teaching hospital
in Marseille for a necrotic wound on the right foot. He treated with
insulin regimens for an uncomplicated and controlled type
2 diabetes mellitus. The patient had no peripheral vascular disease.
During a trip for thalassotherapy in Tunisia in November 2012, he
was admitted to the emergency unit for excoriations and
contusions on his right leg after a fall in a bathroom. A few days
later, he was admitted to the intensive unit care (ICU) for septic
shock, a complication of the skin infection on his right lower leg.
The microbial analysis of blood cultures and wound swabs revealed
negative. He was treated with norepinephrine and three-weeks of
antimicrobial treatment i.e. amoxicillin/clavulanic acid, oﬂoxacin
and fusidic acid. At the three weeks of his hospitalization, he was
discharged from the ICU and was transferred from Tunisian
hospital to the infectious disease unit of the Laveran military
teaching hospital in Marseille, France.
On his arrival in Laveran hospital, he was afebrile, his pulse was
135 beats/min and he was normotensive. The physical examination
showed painless ulcerations with a (7  6 cm) necrotic appearance
on the dorsum of the right foot, (2  1.5 cm) on the plantar of theder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Wound images on his admission.
Fig. 2. Magnetic resonance imaging (MRI) of the leg showed an osteoarthritis of the
midfoot and a talocrural joint effusion associated with a serious loss of skin
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and the (3.5  2 cm) right calf. The extensor digitorum longus
tendons of the third, and fourth toes were exposed with a positive
results of the probe-to-bone test. He also had an induration of the
right leg and the distal portion and inner right thigh (Fig. 1).
Magnetic resonance imaging (MRI) of the leg showed an
osteoarthritis of the midfoot with hypointense on T1 and
hyperintense on T2 of midfoot and a talocrural joint effusion
(Fig. 2) associated with a serious loss of skin substance at level of
the dorsum foot, the lateral malleolus, the talus bone, the right foot
muscles, and tenosynovitis of posterior tibial tendon (Fig. 3).
Laboratory investigations revealed a high level of C-reactive
protein (64.3 mg/L), a normal leukocyte count and a low
hemoglobin concentration (7.5 g/L). Multiple skin and deep
samples tested positive for OXA-48-type carbapenemase-produc-
ing K. pneumoniae. Urine and stool samples also tested positive for
OXA-48-type carbapenemase-producing K. pneumoniae.
In December 2012, he was transferred to the reference center
for bone and infectious disease in Marseille. All antimicrobials
were stopped and hyperbaric oxygen treatment and wound care
including a daily wound cleaning with antiseptic (povidone-
iodine) covered with a sterile dressing with silver (AQUACEL1 Ag
Surgical dressings, ConvaTec Inc), were provided after amultidisciplinary discussion. No topical antibacterial was used
in wound care. The patient was placed in isolation during
hospitalization. The clinical outcome noted a rapid improvement
with persistence only of a clean and healthy wound on the back of
the feet after 30 sessions of hyperbaric oxygen treatment (Fig. 4).substance at level of the dorsum foot.
Fig. 3. Magnetic resonance imaging (MRI) of the leg showed a tenosynovitis of
posterior tibial tendon and loss of skin substance at level of the talus.
62 E. Goerger et al. / IDCases 6 (2016) 60–64We used a multiplace hyperbaric chamber (CxPRO, COMEX1,
Marseille, France) pressurized with compressed air. HBO2 was
performed as usual by using local dive tables derived from the
French COMEX 12, 18 and 30 tables. The chamber was
pressurized to 2.8 atmospheres absolute and patients wereTable 1
Clinical characteristics, therapeutic options and clinical outcomes of the six cases of bo
Study Age
(years)
Sex Site Microbiologic
characteristics
Bacterial
co-infections
This
report
65 Male Right leg (external
malleoli and talus
osteomyelitis)
K. pneumoniae
blaKPC
No 
Gupta
et al.
[5]
32 Male Right femur K. pneumoniae
blaNDM1 gene
No 
De
Sanctis et al. [6]
58 Male Left knee
arthroplasty
K. pneumoniae
blaKPC
Staphylococcu
Alcaligenes fa
Acinetobacter
Candida para
De
Sanctis et al. [6]
72 Male Left knee
arthroplasty
K. pneumoniae
blaKPC
Staphylococcu
Proteus mirab
Acinetobacter
Enterococcus 
De
Sanctis et al. [6]
70 Female Right knee
arthroplasty
K. pneumoniae
blaKPC
Staphylococcu
Streptococcus
pneumoniae,
Corynebacter
Enterococcus 
Córdova
et al.
[7]
Not
mentioned
Not mentioned K. pneumoniae
blaKPC
Not mentiontreated for 60 min with 100% oxygen as previously described
[3]. Standard administration of HBOT was 30 sessions as
previous study [4].
Treatment was given on a once-a-day basis, 5–7 days a week.
Multiple bacteriological cultures of the wounds tested negative
after one month of hyperbaric oxygen treatment and wound care.
The cure of the presumed osteomyelitis in our case was
determined by obtaining a complete healing of skin wounds,
disappearance of pain, a resolution of biological inﬂammatory
signs and by the absence of relapse at one-year follow-up. The
patient was cured, but his urine and stools remained colonized
with OXA-48-type carbapenemase-producing K. pneumoniae one
year after being discharged. No secondary transmission at Laveran
hospital and the reference center was detected.
Discussion
The diagnosis of foot osteomyelitis is often conﬁrmed by bone
histopathology and culture. However, bone biopsies are unobtain-
able in many centers. In many cases, the diagnosis of foot
osteomyelitis can be based on clinical criteria included positive
results of the probe-to-bone test with MRI feature of osteomyelitis.
Since chronic osteomyelitis generally requires debridement for
cure, this presumed osteomyelitis may have been osteomyelitis
although no pathology was available. In this report, we describe
what appeared to be successful treatment of a multidrug-resistant
osteomyelitis caused by OXA-48-type carbapenemase-producing
K. pneumoniae acquired in Tunisia. Bone and joint infections due to
multidrug-resistant bacteria are of increasing interest as they are
extremely difﬁcult to cure due to the lack of appropriate
antimicrobials. OXA-48-type carbapenemase-producing K. pneu-
moniae bone and joint infections have a high mortality and colistin
was previously the only antimicrobials option with tigecycline [1].
Only four cases of carbapenemase-producing K. pneumoniae
osteomyelitis have been previously reported [5–7] (Table 1). All
of these were treated with tigecycline or colistin and surgical
treatment included two-stage exchange arthroplasty in one case,
surgical debridement in one case and prosthesis removal without
re-implantation in two cases. At the end of treatment, only two
patients survived with increase of morbidity and disability. The
antimicrobials used for all the patients were suitable for initiallyne and joint infection caused by carbapenemase-producing K. pneumoniae.
Medical
Treatment
Surgical
treatment
Outcome
Hyperbaric oxygen therapy No Cure
Amikacin, Imipenem/
cilastatin, Rifampin
Surgical debridement Cure
s aureus,
ecalis,
 baumannii,
psilosis
Oxacillin, Piperacillin/
tazobactam, Daptomycin,
Doxycycline, Tigecyclin,
Fluconazole; Colistin,
Amikacin
Two-stage exchange
arthroplasty;
amputation
Death
s aureus,
ilis,
 baumannii,
sp.
Ciproﬂoxacin, Linezolid,
Rifampin, Daptomycin,
Vancomycin, Tigecyclin,
Doxycycline, Oxacillin
Two-stage exchange
arthroplasty
Death
s aureus,
ium sp.,
sp.
Vancomycin, Tigecyclin,
Colistin, Ciproﬂoxacin,
Clindamycin, Amikacin
Two-stage exchange
arthroplasty,
amputation and
disarticulation of right
hip
Cure
ed Antibiotherapy (no detail) Not mentioned Not
mentioned
Fig. 4. Wound images at one month of thirty hyperbaric oxygen sessions.
E. Goerger et al. / IDCases 6 (2016) 60–64 63sensitive strains. Antimicrobial treatment failure has been
explained by the emergence of colistin-resistant KPC-producing
K. pneumoniae.
Application of HBO in infectious disease is not commonly
reported in the literature to date. However, this HBO therapy has
been used for over sixty years in patients with cutaneous and bone
infections as an adjuvant therapy including the treatment of
refractory osteomyelitis [4,8,9] and the treatment of iatrogenic
spinal infections [10,11]. Therapeutic effects of HBO on infections
can be made by direct suppression the growth of anaerobic
bacteria such as clostridia [2], and hyperoxygenation in tissues
causes increase the ﬁbroblasts and collagen proliferation, neo-
vascularization of ischemic tissues and stimulation of bacterial
lysis by leukocytes [2]. This last mechanism can play role in efﬁcacy
of HBO in treatment caused by other aerobic and anaerobic
bacteria.
In our case, HBO combined with local care cured presumed
bacterial osteomyelitis without any antimicrobials. Most of the
cases of bone and joint infection in literature and those of our casewould be different. Nevertheless, when the cases of serious bone
and infection with limiting the efﬁcacy of targeted treatment and
compromising outcomes, HBO should be considered a therapeutic
option without the use of prolonged antimicrobial therapy or wide
surgical excision or in some cases as an adjunctive treatment
option. The apparent beneﬁts of HBO as adjunctive treatment of
bone and joint infection have been reported in some studies. We
believe that the increasing of controlled and randomized studies
would help us to ﬁnding signiﬁcant effects on length of
hospitalization, rapidity of wound repair, initial clinical outcome,
or recurrence of infection. Despite his presumed osteomyelitis
being cured, our patient’s digestive and urinary tracts were still
colonized by the same carbapenemase-producing organism three
years after discharge.
Conclusions
Bone and joint infections due to multidrug-resistant bacteria
are difﬁcult to treat. Carbapenemase-producing K. pneumoniae
64 E. Goerger et al. / IDCases 6 (2016) 60–64bone and joint infection is currently a therapeutic an challenge in
an era of increasingly difﬁcult to treat infections. Antimicrobials
and aggressive surgical procedures seem to be ineffective to date.
Here we report a successful treatment without antimicrobials, only
with HBO and local care. HBO is compatible with the management
and prevention of multi-drug resistant infections and should be
considered if antimicrobial therapy fails.
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